1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

211 - 225 of 233 Results
Sort Results:
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) June 2012
PL Voices: New Once WEEKLY Exenatide (Bydureon) March 2012
Commentary: Using Exenatide (Byetta) with Insulin Glargine (Lantus) December 2011
Commentary: Diabetes Meds and Cardiovascular Risk November 2011
Commentary: Actos (Pioglitazone) and Increased Risk of Bladder Cancer July 2011
Commentary: New Drug: Tradjenta (Linagliptin) June 2011
Guideline: Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) June 2011
Commentary: Metformin vs Pioglitazone for Polycystic Ovary Syndrome May 2011
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Chart: Stepwise Approach to Selecting Treatments for Type 2 Diabetes (AACE) October 2010
Commentary: Restricted Use of Rosiglitazone-Containing Products October 2010
Other: See new FDA information concerning the restricted use of Avandia August 2010
Guideline: Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes (ADA, 2009) August 2010
Commentary: Cardiovascular Safety of Rosiglitazone (Avandia) – 2010 Update August 2010